Swiss Biotech sector boosted by shift toward private funding, report says

Switzerland's biotech industry shifted toward private financing in 2025 as funding from capital markets remained difficult ​to obtain and pharmaceutical companies sought out collaborative deals ‌with biotech firms, a report on the sector showed on Tuesday.